Childhood cancers trials in China

In China 609 Also abroad 2483

609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT
Where
Beijing
Age
12 years to 65 years
People
40
Run by
Peking University People's Hospital
See details and how to joinNCT06984536
No phaseTaking people
A Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach
Where
Beijing
Age
3 years to 75 years
People
100
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07066475
No phaseTaking people
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
Where
Nanjing
Age
Up to 18 years
People
150
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07064746
Phase 1/2Taking people
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
Where
Guangzhou
Age
14 years to 80 years
People
30
Run by
Zhujiang Hospital
See details and how to joinNCT07072494
No phaseTaking people
JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
Where
Kunming
Age
2 years to 75 years
People
36
Run by
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
See details and how to joinNCT07065279
No phaseNot yet taking people in China
Human-AI Collaborative INSIGHT Diagnostic Workflow for in Breast Cancer With Extensive Intraductal Component
Where
Guangzhou
People
480
Run by
Sun Yat-sen University
See details and how to joinNCT07060599
Phase 1/2Taking people
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Where
Beijing
Age
16 years to 85 years
People
90
Run by
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
See details and how to joinNCT07053462
Phase 1/2Taking people
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Where
Beijing
Age
16 years to 85 years
People
90
Run by
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
See details and how to joinNCT07053488
No phaseTaking people
Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale
Where
Guangzhou
People
480
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07051083
No phaseTaking people
Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
Where
Suzhou
People
150
Run by
Zhao Jun
See details and how to joinNCT07047573
No phaseEnrolling by invitation
Explainable Machine Learning for Predicting Early Gastric Cancer
Where
Wenzhou
People
10
Run by
Wenzhou Central Hospital
See details and how to joinNCT07047937
No phaseNot yet taking people in China
Evaluating AI and Human Expert Decisions in Colorectal Cancer
Where
Beijing
People
1,500
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07045207
No phaseTaking people
MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
Where
Shanghai
People
1,000
Run by
Yingbin Liu, MD, PhD, FACS
See details and how to joinNCT07045571
Early phase 1Taking people
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
Where
Shanghai
Age
6 months and over
People
2
Run by
Eye & ENT Hospital of Fudan University
See details and how to joinNCT06424301
Phase 3Not yet taking people in China
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
Where
Shanghai
Age
5 years to 18 years
People
100
Run by
Shanghai Children's Medical Center
See details and how to joinNCT07035821
Phase 1/2Taking people
Clinical Study of U32 in Patients With Acute Myeloid Leukemia
Where
Suzhou
Age
2 years to 65 years
People
20
Run by
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
See details and how to joinNCT07036250
No phaseTaking people
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
Where
Taiyuan
Age
14 years to 75 years
People
50
Run by
Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT05618041
No phaseTaking people
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
Where
Beijing, Tianjin, Wuhan, Zhengzhou
People
1,500
Run by
Nanjing IASO Biotechnology Co., Ltd.
See details and how to joinNCT07028970
No phaseTaking people
Noninvasive Intratumor Heterogeneity Evaluation in HNSCC
Where
Chongqing
Age
15 years to 89 years
People
700
Run by
First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07027280
Phase 2Taking people
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Where
Guangzhou
Age
12 months and over
People
120
Run by
Sun Yat-Sen University Cancer Center
See details and how to joinNCT06013618
No phaseTaking people
National Longitudinal Cohort of Hematological Diseases (NICHE) - CART
Where
Tianjin
People
1,000
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06607289
Early phase 1Enrolling by invitation
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Where
Wuxi
Age
15 years to 75 years
People
20
Run by
Affiliated Hospital of Jiangnan University
See details and how to joinNCT07023861
Phase 1/2Not yet taking people in China
Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1
Where
Shanghai
Age
2 years to 20 years
People
65
Run by
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
See details and how to joinNCT07024394
Phase 2Not yet taking people in China
Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer
Where
Beijing
Age
16 years to 45 years
People
35
Run by
zhoujing
See details and how to joinNCT07018063
No phaseTaking people
The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
Where
Guangzhou
Age
1 year to 18 years
People
60
Run by
Sun Yat-sen University
See details and how to joinNCT04957901